4.3 Article

Prognostic potential of the small GTPase Ran and its methylation in hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer

Johann von Felden et al.

Summary: This study found that unannotated small RNAs are a major component of exRNA smRCs, with an unannotated 3-smRC signature significantly overexpressed in plasma exRNA of HCC patients. In a phase 2 biomarker case-control study, this 3-smRC signature showed 86% sensitivity and 91% specificity for detecting early HCC from at-risk controls.
Article Biotechnology & Applied Microbiology

Global analysis of DNA methylation in hepatocellular carcinoma via a whole-genome bisulfite sequencing approach

Qian Yan et al.

Summary: This study investigated alterations in DNA methylation patterns in hepatocellular carcinoma (HCC) using whole-genome bisulfite sequencing technology. The research identified a genome-wide hypomethylation pattern in HCC, with hyper-DMGs mainly involved in metabolism pathways and hypo-DMGs mainly involved in cell adhesion. By constructing a prognostic model based on aberrantly methylated genes, the study provided insights into the epigenetic mechanisms of HCC development.

GENOMICS (2021)

Article Biochemistry & Molecular Biology

Molecular Associations and Clinical Significance of RAPs in Hepatocellular Carcinoma

Sarita Kumari et al.

Summary: The study found that the RAP gene family is dysregulated in hepatocellular carcinoma, with RAP2A showing the strongest ability to differentiate tumors and being associated with tumor progression, gene mutations, and DNA methylation. RAP2A can also serve as an independent prognostic marker for patients. Additionally, pathway analysis revealed associations between RAP2A expression and tumor-infiltrating immune cells and oncogenic molecular pathways.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biochemistry & Molecular Biology

Promoter aberrant methylation status of ADRA1A is associated with hepatocellular carcinoma

Guoqiao Chen et al.

EPIGENETICS (2020)

Review Cell Biology

Ran GTPase: A Key Player in Tumor Progression and Metastasis

Zied Boudhraa et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

EIF4G1andRANas Possible Drivers for Malignant Pleural Mesothelioma

Irene Dell'Anno et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Ran promotes membrane targeting and stabilization of RhoA to orchestrate ovarian cancer cell invasion

Kossay Zaouil et al.

NATURE COMMUNICATIONS (2019)

Article Cell Biology

Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma

Young K. Hong et al.

CELLULAR IMMUNOLOGY (2019)

Review Medicine, General & Internal

Principles of DNA methylation and their implications for biology and medicine

Yuval Dor et al.

LANCET (2018)

Review Gastroenterology & Hepatology

Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics

Faisal Saeed Khan et al.

HEPATOLOGY INTERNATIONAL (2017)

Article Oncology

Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival

Ahmedin Jemal et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Article Oncology

Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival

Ahmedin Jemal et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Review Immunology

Regulatory T cells in cancer immunotherapy

Hiroyoshi Nishikawa et al.

CURRENT OPINION IN IMMUNOLOGY (2014)

Article Biochemistry & Molecular Biology

Activation of the Ran GTPase Is Subject to Growth Factor Regulation and Can Give Rise to Cellular Transformation

Thi K. Ly et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Analysis of a RanGTP-regulated gradient in mitotic somatic cells

P Kaláb et al.

NATURE (2006)